£885.00

It has never been this cheap. We have no record of a lower price.

£885 today · cheaper than every other day in the last 1 months

The 2026-2031 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 4 days · 4 data points (no recent data)

Historical
Generating forecast…
£885.00 £840.75 £858.45 £876.15 £893.85 £911.55 £929.25 10 September 2026 10 September 2026 11 September 2026 12 September 2026 13 September 2026
View at Amazon ↗

Price data last checked 38 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 4 days • 1 price levels

Days at Price
4 days 0 1 2 3 4 £885 Days at Price

Price Analysis

Most common price: £885 (4 days, 100.0%)

Price range: £885 - £885

Price levels: 1 different prices over 4 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
04 June 2025
Listed Since
03 July 2025

Similar Products You Might Like

The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments
97% match

The 2025-2030 World Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments

£790.00 14 Sep 2026
The 2026-2031 World Outlook for Liver Cancer Diagnostics
95% match

The 2026-2031 World Outlook for Liver Cancer Diagnostics

£885.00 14 Sep 2026
The 2026-2031 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics
94% match

The 2026-2031 World Outlook for Acute Lymphocytic-Lymphoblastic Leukemia Therapeutics

£885.00 04 Sep 2026
The 2026-2031 World Outlook for Kidney Cancer Drugs
94% match

The 2026-2031 World Outlook for Kidney Cancer Drugs

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Kidney Cancer-Treating Drugs
94% match

The 2026-2031 World Outlook for Kidney Cancer-Treating Drugs

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics
94% match

The 2026-2031 World Outlook for Exocrine Pancreatic Insufficiency Therapeutics

£885.00 07 Aug 2026
The 2026-2031 World Outlook for Chronic Obstructive Pulmonary Disease Treatments
94% match

The 2026-2031 World Outlook for Chronic Obstructive Pulmonary Disease Treatments

£885.00 16 Oct 2026
The 2026-2031 World Outlook for In-Vitro Colorectal Cancer Screening Tests
94% match

The 2026-2031 World Outlook for In-Vitro Colorectal Cancer Screening Tests

£885.00 14 Sep 2026
The 2026-2031 World Outlook for Non-Melanoma Skin Cancers
94% match

The 2026-2031 World Outlook for Non-Melanoma Skin Cancers

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Malignant Mesothelioma
94% match

The 2026-2031 World Outlook for Malignant Mesothelioma

£885.00 21 Oct 2026
The 2025-2030 World Outlook for Non-Hematological Cancer Treatments
94% match

The 2025-2030 World Outlook for Non-Hematological Cancer Treatments

£790.00 13 Sep 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments
94% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases Treatments

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma
93% match

The 2026-2031 World Outlook for Premetrexed and Combinations for Malignant Mesothelioma

£885.00 31 Aug 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics
93% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases Therapeutics

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Somatostatin Analogs Treatments
93% match

The 2026-2031 World Outlook for Somatostatin Analogs Treatments

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings
93% match

The 2026-2031 World Outlook for Fecal Occult Blood Tests for In-Vitro Colorectal Cancer Screenings

£885.00 20 Oct 2026
The 2026-2031 World Outlook for Oligonucleotide Therapeutics
93% match

The 2026-2031 World Outlook for Oligonucleotide Therapeutics

£885.00 21 Oct 2026
The 2026-2031 World Outlook for Biotherapeutics Cell Line Transfection and Selection
93% match

The 2026-2031 World Outlook for Biotherapeutics Cell Line Transfection and Selection

£885.00 29 Aug 2026
The 2027-2032 World Outlook for Bladder Cancer Therapeutics
93% match

The 2027-2032 World Outlook for Bladder Cancer Therapeutics

£890.00 21 Oct 2026
The 2026-2031 World Outlook for Renal Anemia Treatments
93% match

The 2026-2031 World Outlook for Renal Anemia Treatments

£885.00 21 Oct 2026
The 2026-2031 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research
92% match

The 2026-2031 World Outlook for 3D Cell Cultures for Cancer and Stem Cell Research

£885.00 14 Sep 2026
The 2026-2031 World Outlook for Hydroxychloroquine
92% match

The 2026-2031 World Outlook for Hydroxychloroquine

£885.00 21 Sep 2026
The 2026-2031 World Outlook for Lysosomal Storage Diseases
92% match

The 2026-2031 World Outlook for Lysosomal Storage Diseases

£885.00 29 Aug 2026
The 2026-2031 World Outlook for Bone Morphogenetic Proteins
92% match

The 2026-2031 World Outlook for Bone Morphogenetic Proteins

£885.00 16 Oct 2026